Fig. 4From: Biological and clinical impact of membrane EGFR expression in a subgroup of OC patients from the phase IV ovarian cancer MITO-16A/MANGO-OV2A trialGraphical representation of the genes/functions predicted by IPA performed using the differential gene expression derived by comparing MM vs M and MO groups of patients. IPA was run using the log fold changes of the genes up- or down-modulated in MM vs the other two subgroups and included in the EGFR-related gene sets reported in Table 4. See Methods for details of the analysis. The name of each gene set is reported above each scheme. Panel in the right side, prediction legendsBack to article page